Pilot trials on the treatment of Dermatobia hominis infections in cattle with closantel.
The therapeutic and prophylactic activities of closantel given to calves inoculated with larvae of Dermatobia hominis were studied. Calves (n = 9 principals, plus 3 nontreated controls) were given closantel at different dosages (8 to 12.5 mg/kg) and schedules of treatment. The largest dosage of closantel (12.5 mg/kg) had the most efficacious therapeutic activity (97.3%). Prophylactic activity was also seen in calves given the drug before they were experimentally inoculated.
D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use*; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy* / Q000517:prevention & control; D004175:Diptera / Q000187:drug effects; D007814:Larva / Q000187:drug effects; D009198:Myiasis / Q000188:drug therapy / Q000517:prevention & control / Q000662:veterinary*; D010865:Pilot Projects; D012457:Salicylamides / Q000627:therapeutic use*; D012458:Salicylanilides / Q000008:administration & dosage / Q000627:therapeutic use*
D000871:Anthelmintics; D012457:Salicylamides; D012458:Salicylanilides; C023342:closantel